All lobbying filings
Michael J. Lamoureux
Michael J. Lamoureux filed a Q3 report for Amgen Inc. on October 22, 2026.
Lobbying for Amgen Inc. · Biotechnology
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 22, 2026
Money reported
None
Registrations and no-activity reports carry no figure.
Client based in
District of Columbia
Government bodies contacted
1
Lobbying activity
1
Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests